Quantitative MR T2 measurement of articular cartilage to assess the treatment effect of intra-articular hyaluronic acid injection on experimental osteoarthritis induced by ACLX

Osteoarthritis and Cartilage

Volumn 18, Issue 1, 2010, Pages 54-60

  Huang, G S ^a   Lee, H S ^a   Chou, M C ^a,b   Shih, Y Y I ^c   Tsai, P H ^a,d   Lin, M H ^c   Lin, C Y ^c   Lee, C H ^e   Chung, H W ^a,d  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT INJURY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; FEASIBILITY STUDY; HISTOPATHOLOGY; KNEE OSTEOARTHRITIS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SCORING SYSTEM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTERIOR CRUCIATE LIGAMENT; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MAGNETIC RESONANCE IMAGING; MALE; OSTEOARTHRITIS, KNEE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 72149113324     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.08.014     Document Type: Article

References (41)

1. Goldberg V.M., and Buckwalter J.A. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 13 (2005) 216-224
2. Abadie E., Ethgen D., Avouac B., Bouvenot G., Branco J., Bruyere O., et al. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis. Osteoarthritis Cartilage 12 (2004) 263-268
3. Altman R.D., and Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 25 (1998) 2203-2212
4. Brandt K.D., Block J.A., Michalski J.P., Moreland L.W., Caldwell J.R., and Lavin P.T. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res 385 (2001) 130-143
5. Dougados M. Sodium hyaluronate therapy in osteoarthritis: arguments for a potential beneficial structural effect. Semin Arthritis Rheum 30 (2000) 19-25
6. Dougados M., Nguyen M., Listrat V., and Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1 (1993) 97-103
7. Huskisson E.C., and Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford) 38 (1999) 602-607
8. Wobig M., Bach G., Beks P., Dickhut A., Runzheimer J., Schwieger G., et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 21 (1999) 1549-1562
9. Wobig M., Dickhut A., Maier R., and Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20 (1998) 410-423
10. Jubb R.W., Piva S., Beinat L., Dacre J., and Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract 57 (2003) 467-474
11. Cubukcu D., Ardic F., Karabulut N., Topuz O., and Hylan G.-F. 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol 24 (2005) 336-341
12. Frizziero L., Govoni E., and Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 16 (1998) 441-449
13. Guidolin D.D., Ronchetti I.P., Lini E., Guerra D., and Frizziero L. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthritis Cartilage 9 (2001) 371-381
14. Listrat V., Ayral X., Patarnello F., Bonvarlet J.P., Simonnet J., Amor B., et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 5 (1997) 153-160
15. Pasquali Ronchetti I., Guerra D., Taparelli F., Boraldi F., Bergamini G., Mori G., et al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology (Oxford) 40 (2001) 158-169
16. Rovati L.C. Radiographic assessment. Introduction: existing methodology. Osteoarthritis Cartilage 7 (1999) 427-429
17. Blumenkrantz G., and Majumdar S. Quantitative magnetic resonance imaging of articular cartilage in osteoarthritis. Eur Cell Mater 13 (2007) 76-86
18. Raynauld J.P. Quantitative magnetic resonance imaging of articular cartilage in knee osteoarthritis. Curr Opin Rheumatol 15 (2003) 647-650
19. Burstein D. MRI for development of disease-modifying osteoarthritis drugs. NMR Biomed 19 (2006) 669-680
20. Glaser C. New techniques for cartilage imaging: T2 relaxation time and diffusion-weighted MR imaging. Radiol Clin North Am 43 (2005) 641-653
21. Miller K.L., Hargreaves B.A., Gold G.E., and Pauly J.M. Steady-state diffusion-weighted imaging of in vivo knee cartilage. Magn Reson Med 51 (2004) 394-398
22. Bashir A., Gray M.L., and Burstein D. Gd-DTPA2- as a measure of cartilage degradation. Magn Reson Med 36 (1996) 665-673
23. Gray M.L., Eckstein F., Peterfy C., Dahlberg L., Kim Y.J., and Sorensen A.G. Toward imaging biomarkers for osteoarthritis. Clin Orthop Relat Res 427 (2004) S175-S181
24. Koff M.F., Amrami K.K., and Kaufman K.R. Clinical evaluation of T2 values of patellar cartilage in patients with osteoarthritis. Osteoarthritis Cartilage 15 (2007) 198-204
25. Dunn T.C., Lu Y., Jin H., Ries M.D., and Majumdar S. T2 relaxation time of cartilage at MR imaging: comparison with severity of knee osteoarthritis. Radiology 232 (2004) 592-598
26. Mosher T.J., Dardzinski B.J., and Smith M.B. Human articular cartilage: influence of aging and early symptomatic degeneration on the spatial variation of T2-preliminary findings at 3 T. Radiology 214 (2000) 259-266
27. Spandonis Y., Heese F.P., and Hall L.D. High resolution MRI relaxation measurements of water in the articular cartilage of the meniscectomized rat knee at 4.7 T. Magn Reson Imaging 22 (2004) 943-951
28. Watrin-Pinzano A., Ruaud J.P., Cheli Y., Gonord P., Grossin L., Gillet P., et al. T2 mapping: an efficient MR quantitative technique to evaluate spontaneous cartilage repair in rat patella. Osteoarthritis and Cartilage 12 (2004) 191-200
29. Watrin-Pinzano A., Ruaud J.P., Olivier P., Grossin L., Gonord P., Blum A., et al. Effect of proteoglycan depletion on T2 mapping in rat patellar cartilage. Radiology 234 (2005) 162-170
30. Chou M.C., Tsai P.H., Huang G.S., Lee H.S., Lee C.H., Lin M.H., et al. Correlation between the MR T2 value at 4.7 T and relative water content in articular cartilage in experimental osteoarthritis induced by ACL transection. Osteoarthritis Cartilage 17 (2009) 441-447
31. Jean Y.H., Wen Z.H., Chang Y.C., Lee H.S., Hsieh S.P., Wu C.T., et al. Hyaluronic acid attenuates osteoarthritis development in the anterior cruciate ligament-transected knee: association with excitatory amino acid release in the joint dialysate. J Orthop Res 24 (2006) 1052-1061
32. Mankin H.J., Dorfman H., Lippiello L., and Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J. Bone and Joint Surg 53 (1971) 523-537
33. Atkinson G., and Nevill A.M. Statistical methods for assessing measurement error (reliability) in variables relevant to sports medicine. Sports Med 26 (1998) 217-238
34. Kuettner K.E., Aydelotte M.B., and Thonar E.J. Articular cartilage matrix and structure: a minireview. J Rheumatol Suppl 27 (1991) 46-48
35. Liess C., Lusse S., Karger N., Heller M., and Gluer C.C. Detection of changes in cartilage water content using MRI T2-mapping in vivo. Osteoarthritis Cartilage 10 (2002) 907-913
36. Lusse S., Claassen H., Gehrke T., Hassenpflug J., Schunke M., Heller M., et al. Evaluation of water content by spatially resolved transverse relaxation times of human articular cartilage. Magn Reson Imaging 18 (2000) 423-430
37. Sweet M.B., Thonar E.J., Immelman A.R., and Solomon L. Biochemical changes in progressive osteoarthrosis. Ann Rheum Dis 36 (1977) 387-398
38. Goodwin D.W., and Dunn J.F. High-resolution magnetic resonance imaging of articular cartilage: correlation with histology and pathology. Top Magn Reson Imaging 9 (1998) 337-347
39. Xia Y. Magic-angle effect in magnetic resonance imaging of articular cartilage: a review. Invest Radiol 35 (2000) 602-621
40. Peterfy C.G., Janzen D.L., Tirman P.F.J., Dijke C.F.V., Pollack M., and Genant H.K. "Magic-angle" phenomenon: a cause of increased signal in the normal lateral meniscus on short-TE MR images of the knee. AJR Am J Roentgenol 163 (1994) 149-154
41. Bydder M., Rahal A., Fullerton G.D., and Byder G.M. The magic angle effect: a source of artifact, determinant of image contrast, and technique for imaging. J Magn Reson Imaging 25 (2007) 290-300